APA (7th ed.) Citation

C, T., D, D., M, W., G, M., HH, N., PR, E., & F, M. (2026). Atypical femoral fracture with early PET/CT changes from denosumab for metastatic breast cancer and transition from denosumab to zoledronic acid. Bone, 206, 117821. https://doi.org/10.1016/j.bone.2026.117821

Chicago Style (17th ed.) Citation

C, Tan, Day D, White M, Man G, Nguyen HH, Ebeling PR, and Milat F. "Atypical Femoral Fracture with Early PET/CT Changes from Denosumab for Metastatic Breast Cancer and Transition from Denosumab to Zoledronic Acid." Bone 206 (2026): 117821. https://doi.org/10.1016/j.bone.2026.117821.

MLA (9th ed.) Citation

C, Tan, et al. "Atypical Femoral Fracture with Early PET/CT Changes from Denosumab for Metastatic Breast Cancer and Transition from Denosumab to Zoledronic Acid." Bone, vol. 206, 2026, p. 117821, https://doi.org/10.1016/j.bone.2026.117821.